Patricia LiWang was at an impasse.
It was 2011 and the UC Merced professor’s research group had figured out how to make some of the most potent HIV inhibitors even more powerful. LiWang was thrilled by these findings; funding agencies like the National Institutes of Health (NIH) weren’t.
“Our...